Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Fleming, Jodie M ^a,b   Ginsburg, Erika ^a   Goldhar, Anita S ^a   Plant, Joshua ^a   Vonderhaar, Barbara K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; PROGESTERONE RECEPTOR; PROTEIN ALK2; RECEPTOR PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TISSUE NON SPECIFIC ALKALINE PHOSPHATASE; TRANSCRIPTION FACTOR MSX2; UNCLASSIFIED DRUG; ALKALINE PHOSPHATASE 2, MOUSE; HOMEODOMAIN PROTEIN; PRIMER DNA;

AKP2 GENE; ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; GENE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CYTOLOGY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; UDDER;

ALKALINE PHOSPHATASE; ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; DNA PRIMERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HOMEODOMAIN PROTEINS; MAMMARY GLANDS, ANIMAL; MICE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 84858734443     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034058     Document Type: Article

References (46)

1. Aupperlee MD, Haslam SZ, (2007) Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 148: 2290-2300.
2. Shyamala G, Yang X, Cardiff RD, Dale E, (2000) Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci U S A 97: 3044-3049.
3. Pinkas J, Leder P, (2002) MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res 62: 4781-4790.
4. Haslam SZ, Shyamala G, (1980) Progesterone receptors in normal mammary gland: receptor modulations in relation to differentiation. J Cell Biol 86: 730-737.
5. Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, et al. (2001) Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn 222: 192-205.
6. Satoh K, Hovey RC, Malewski T, Warri A, Goldhar AS, et al. (2007) Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene 26: 7526-7534.
7. Malewski T, Milewicz T, Krzysiek J, Gregoraszczuk EL, Augustowska K, (2005) Regulation of Msx2 gene expression by steroid hormones in human nonmalignant and malignant breast cancer explants cultured in vitro. Cancer Invest 23: 222-228.
8. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, et al. (2000) Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14: 650-654.
9. Mishina Y, Crombie R, Bradley A, Behringer RR, (1999) Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev Biol 213: 314-326.
10. Ahn K, Mishina Y, Hanks MC, Behringer RR, Crenshaw EB 3rd, (2001) BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development 128: 4449-4461.
11. Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, et al. (1996) Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development 122: 2729-2737.
12. Flanders KC, Kim ES, Roberts AB, (2001) Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas. Dev Dyn 220: 141-154.
13. Gu Z, Reynolds EM, Song J, Lei H, Feijen A, et al. (1999) The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development 126: 2551-2561.
14. Eblaghie MC, Reedy M, Oliver T, Mishina Y, Hogan BL, (2006) Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells. Dev Biol 291: 67-82.
15. Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V, (2004) Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech Dev 121: 173-182.
16. Tylzanowski P, Verschueren K, Huylebroeck D, Luyten FP, (2001) Smad-interacting protein 1 is a repressor of liver/bone/kidney alkaline phosphatase transcription in bone morphogenetic protein-induced osteogenic differentiation of C2C12 cells. J Biol Chem 276: 40001-40007.
17. Fialka I, Schwarz H, Reichmann E, Oft M, Busslinger M, et al. (1996) The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J Cell Biol 132: 1115-1132.
18. Fleming JM, Long EL, Ginsburg E, Gerscovich D, Meltzer PS, et al. (2008) Interlobular and intralobular mammary stroma: genotype may not reflect phenotype. BMC Cell Biol 9: 46-57.
19. Terao M, Studer M, Gianni M, Garattini E, (1990) Isolation and characterization of the mouse liver/bone/kidney-type alkaline phosphatase gene. Biochem J 268: 641-648.
20. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
21. Goldhar AS, Duan R, Ginsburg E, Vonderhaar BK, (2011) Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP. Mol Cell Endocrinol 335: 148-157.
22. Jacobsen BM, Richer JK, Schittone SA, Horwitz KB, (2002) New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. J Biol Chem 277: 27793-27800.
23. Badtke MM, Jambal P, Dye WW, Spillman MA, Post MD, et al. (2012) Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpoint. Breast Cancer Res Treat 131: 75-87.
24. Jacobsen BM, Schittone SA, Richer JK, Horwitz KB, (2005) Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. Mol Endocrinol 19: 574-587.
25. Lieberman BA, Bona BJ, Edwards DP, Nordeen SK, (1993) The constitution of a progesterone response element. Mol Endocrinol 7: 515-527.
26. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, et al. (1999) Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 84: 4559-4565.
27. Raafat AM, Hofseth LJ, Li S, Bennett JM, Haslam SZ, (1999) A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice. Endocrinology 140: 2570-2580.
28. Wang S, Counterman LJ, Haslam SZ, (1990) Progesterone action in normal mouse mammary gland. Endocrinology 127: 2183-2189.
29. Obr A, Edwards DP, (2011) The biology of progesterone receptor in the normal mammary gland and in breast cancer. Mol Cell Endocrinol http://dx.doi.org/10.1016/j.mce.2011.10.03.
30. Carnevale RP, Proietti CJ, Salatino M, Urtreger A, Peluffo G, et al. (2007) Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. Mol Endocrinol 21: 1335-1358.
31. Hens JR, Dann P, Zhang JP, Harris S, Robinson GW, et al. (2007) BMP4 and PTHrP interact to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction. Development 134: 1221-1230.
32. di Bari MG, Ginsburg E, Plant J, Strizzi L, Salomon DS, et al. (2009) Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1. J Cell Physiol 219: 659-666.
33. Faivre EJ, Lange CA, (2007) Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 27: 466-480.
34. Willert J, Epping M, Pollack JR, Brown PO, Nusse R, (2002) A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2: 8.
35. de la Pena LS, Billings PC, Fiori JL, Ahn J, Kaplan FS, et al. (2005) Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res 20: 1168-1176.
36. Herrera B, van Dinther M, Ten Dijke P, Inman GJ, (2009) Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res 69: 9254-9262.
37. Craft CS, Romero D, Vary CP, Bergan RC, (2007) Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway. Oncogene 26: 7240-7250.
38. Na YR, Seok SH, Kim DJ, Han JH, Kim TH, et al. (2009) Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci 100: 2218-2225.
39. Fukuda T, Kohda M, Kanomata K, Nojima J, Nakamura A, et al. (2009) Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem 284: 7149-7156.
40. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, et al. (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164: 1199-1209.
41. Fisher JL, Thomas-Mudge RJ, Elliott J, Hards DK, Sims NA, et al. (2006) Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically. Cancer Res 66: 3620-3628.
42. Deckers M, van Dinther M, Buijs J, Que I, Lowik C, et al. (2006) The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66: 2202-2209.
43. Oka H, Kondoh T, Seichi A, Hozumi T, Nakamura K, (2006) Incidence and prognostic factors of Japanese breast cancer patients with bone metastasis. J Orthop Sci 11: 13-19.
44. Ghosh-Choudhury N, Singha PK, Woodruff K, St Clair P, Bsoul S, et al. (2006) Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression. J Biol Chem 281: 20160-20170.
45. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, et al. (2010) Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16: 1400-1406.
46. Wang J, Sridurongrit S, Dudas M, Thomas P, Nagy A, et al. (2005) Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev Biol 286: 299-310.